VERifyNow in diabetes high-on-treatment platelet reactivity: A pharmacodynamic study on switching from clopidogrel to prasugrel

Acta Cardiologica

Volumn 70, Issue 6, 2015, Pages 728-734

  Cubero Gómez, José M ^a   Acosta Martínez, Juan ^a   Mendias Benítez, Cristina ^a   Díaz De La Llera, Luis S ^a   Fernández Quero, Mónica ^a   Guisado Rasco, Agustín ^a   Villa Gil Ortega, Manuel ^a   Sánchez González, Ángel ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

Author keywords

Acute coronary syndrome; Diabetes; Platelet reactivity; Prasugrel; VerifyNow

Indexed keywords

CLOPIDOGREL; CREATININE; GLYCOPROTEIN; HEMOGLOBIN; PRASUGREL; PURINERGIC P2Y12 RECEPTOR; ANTITHROMBOCYTIC AGENT; TICLOPIDINE;

ACUTE CORONARY SYNDROME; ADULT; AGED; ANGIOPLASTY; ARTICLE; BLEEDING; CELL AGGREGATION; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES HIGH ON TREATMENT PLATELET REACTIVITY; DRUG ELUTING STENT; DRUG INDUCED DISEASE; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HEART INFARCTION; HEMATOCRIT; HUMAN; KIDNEY FAILURE; LOADING DRUG DOSE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PLATELET REACTIVITY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SINGLE DRUG DOSE; ST SEGMENT ELEVATION; ANALOGS AND DERIVATIVES; BLOOD; BLOOD CLOTTING PARAMETERS; COMPLICATION; DIABETES MELLITUS, TYPE 2; DOSE RESPONSE; DRUG EFFECTS; SINGLE BLIND PROCEDURE; THROMBOCYTE; TREATMENT OUTCOME;

ACUTE CORONARY SYNDROME; AGED; BLOOD PLATELETS; DIABETES MELLITUS, TYPE 2; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; PERCUTANEOUS CORONARY INTERVENTION; PLATELET AGGREGATION INHIBITORS; PLATELET FUNCTION TESTS; PRASUGREL HYDROCHLORIDE; PROSPECTIVE STUDIES; SINGLE-BLIND METHOD; TICLOPIDINE; TREATMENT OUTCOME;

EID: 84949980973     PISSN: 00015385     EISSN: 03737934     Source Type: Journal    
DOI: 10.2143/AC.70.6.3120187     Document Type: Article

References (19)

1. Levine GN, Bates ER, Blankenship JC, Bailey SR, Bittl JA, Cercek B, Chambers CE, Ellis SG, Guyton RA, Hollenberg SM, Khot UN, Lange RA, Mauri L, Mehran R, Moussa ID, Mukherjee D, Nallamothu BK, Ting HH. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. Circulation 2011; 124: e574-e651.
2. Nguyen T, Diodati J, Pharand C. Resistance to clopidogrel: a review of the evidence. J Am Coll Cardiol 2005; 45: 1157-64.
3. Gurbel P, Bliden K, Hiatt B, O’Connor C. Clopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivity. Circulation 2003; 107: 2908-13.
4. von Beckerath N, Taubert D, Pogatsa-Murray G, Schomig E, Kastrati A, Schomig E. Absorption, metabolization, and antiplatelet effects of 300-, 600-, and 900-mg loading doses of clopidogrel: results of the ISAR-CHOICE (Intracoronary Stenting and Antithrombotic Regimen: Choose Between 3 High Oral Doses for Immediate Clopidogrel Effect) Trial. Circulation 2005; 112: 2946-50.
5. Stone G, Witzenbichler B, Weisz G, Rinaldi M, Neumann F, Metzger C, Henry T, Cox D, Duffy P, Mazzaferri E, Gurbel P, Xu K, Parise H, Kirtane A, Brodie B, Mehran R, Stuckey T, ADAPT-DES Investigators. Platelet reactivity and clinical outcomes after coronary artery implantation of drug-eluting stents (ADAPT-DES): a prospective multicentre registry study. The Lancet 2013: 382: 614-23.
6. Angiolillo D, Fernandez-Ortiz A, Bernardo E, Ramirez C, Sabate M, Jimenez-Quevedo P, Hernandez R, Moreno R, Escaned J, Alfonso F, Banuelos C, Costa M, Bass T, Macaya C. Platelet function in patients with type 2 diabetes and coronary artery disease on combined aspirin and clopidogrel treatment. Diabetes 2005; 54: 2430-5.
7. Scheen A, Legrand D. Aspirin and clopidogrel resistance in patients with diabetes mellitus. Eur Heart J 2006; 27: 2900-1.
8. Angiolillo DJ, Badimon JJ, Saucedo JF, Frelinger AL, Michelson AD, Jakubowski JA, Zhu B, Ojeh CK, Baker BA, Effron MB. A pharmacodynamic comparison of prasugrel vs. high-dose clopidogrel in patients with type 2 diabetes mellitus and coronary artery disease: results of the Optimizing anti-Platelet Therapy In diabetes MellitUS (OPTIMUS)-3 Trial. Eur Heart J 2011; 32: 838-46.
9. Wiviott SD, Braunwald E, Angiolillo DJ, Meisel S, Dalby AJ, Verheugt FW, Goodman SG, Corbalan R, Purdy DA, Murphy SA, McCabe CH, Antman EM; TRITON-TIMI 38 Investigators. Greater clinical benefit of more intensive oral antiplatelet therapy with prasugrel in patients with diabetes mellitus in the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-Thrombolysis in Myocardial Infarction 38. Circulation 2008; 118: 1626-36.
10. Saucedo JF. Antiplatelet therapy for patients with diabetes mellitus and acute coronary syndrome. Primary care diabetes 2012; 6: 167-77.
11. Collet J-P, Cuisset T, Range G, Cayla G, Elhadad S, Pouillot C, Henry P, Motreff P, Carrie D, Boueri Z, Belle L, Van Belle E, Rousseau H, Aubry P, Monsegu J, Sabouret P, O’Connor SA, Abtan J, Kerneis M, Saint-Etienne C, Barthelemy O, Beygui F, Silvain J, Vicaut E, Montalescot G; ARCTIC Investigators. Bedside monitoring to adjust antiplatelet therapy for coronary stenting. New Engl J Med 2012; 367: 2100-9.
12. Price MJ, Berger PB, Teirstein PS, Tanguay J-F, Angiolillo DJ, Spriggs D, Puri S, Robbins M, Garratt KN, Bertrand OF, Stillabower ME, Stillablower ME, Aragon JR, Kandzari DE, Stinis CT, Lee MS, Manoukian SV, Cannon CP, Schork NJ, Topol EJ; GRAVITAS Investigators. Standard- vs high-dose clopidogrel based on platelet function testing after percutaneous coronary intervention: the GRAVITAS randomized trial. JAMA 2011; 305: 1097-105.
13. Trenk D, Stone GW, Gawaz M, Kastrati A, Angiolillo DJ, Muller U, Richardt G, Jakubowski JA, Neumann F-J. A randomized trial of prasugrel versus clopidogrel in patients with high platelet reactivity on clopidogrel after elective percutaneous coronary intervention with implantation of drug-eluting stents: results of the TRIGGER-PCI (Testing Platelet Reactivity In Patients Undergoing Elective Stent Placement on Clopidogrel to Guide Alternative Therapy With Prasugrel) study. J Am Coll Cardiol 2012; 59: 2159-64.
14. Collet JP, Cayla G, Cuisset T, Elhadad S, Range G, Vicaut E, Montalescot G Randomized comparison of platelet function monitoring to adjust antiplatelet therapy versus standard of care: rationale and design of the assessment with a double randomization of (1) a fixed dose versus a monitoring-guided dose of aspirin and clopidogrel after DES implantation, and (2) treatment interruption versus continuation, 1 year after stenting (ARCTIC) study. Am Heart J 2011; 161: 5-12 e5.
15. Trenk D, Hochholzer W, Fromm M, Chialda L, Pahl A, Valina C, Stratz C, Schmiebusch P, Bestehorn H, Buttner H, Neumann F. Cytochrome P450 2C19 681G> A polymorphism and high on-clopidogrel platelet reactivity associated with adverse 1-year clinical outcome of elective percutaneous coronary intervention with drug-eluting of bare-metal stents. J Am Coll Cardiol 2008; 51: 1925-34.
16. Cubero J, Navarro Puerto M, De Mier-Barragan M. CANDY study: minor myocardial damage in patients with type 2 diabetes mellitus and dual hypo-responsiveness to aspirin and clopidogrel with Xience V stent implantation. J Am Coll Cardiol 2012; 59: E488-E488 (doi:10.1016/S0735-1097(12)60489-6).
17. Stone GW, Witzenbichler B, Weisz G, Rinaldi MJ, Neumann FJ, Metzger DC, Henry TD, Cox DA, Duffy PL, Mazzaferri E, Gurbel PA, Xu K, Parise H, Kirtane AJ, Brodie BR, Mehran R, Stuckey TD. Platelet reactivity and clinical outcomes after coronary artery implantation of drug-eluting stents (ADAPT-DES): a prospective multicentre registry study. Lancet 2013; 382: 614-23.
18. Kurz DJ, Radovanovic D, Seifert B, Bernheim AM, Roffi M, Pedrazzini G, Windecker S, Erne P, Eberli FR. Comparison of prasugrel and clopidogrel-treated patients with acute coronary syndrome undergoing percutaneous coronary intervention: A propensity score-matched analysis of the Acute Myocardial Infarction in Switzerland (AMIS)-Plus Registry. Eur Heart J Acute Cardiovasc Care 2015 Jan 22. pii: 2048872614566946. [Epub ahead of print].
19. Angiolillo DJ, Ueno M, Goto S. Basic principles of platelet biology and clinical implications. Circ J 2010; 74: 597-607.